A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system-Reference-Cited by-同舟云学术

A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system

Published:2010-07 Issue:1 Volume:53 Page:108-117
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Hsu Chia-Yang,Huang Yi-Hsiang,Hsia Cheng-Yuan,Su Chien-Wei,Lin Han-Chieh,Loong Che-Chuan,Chiou Yi-You,Chiang Jen-Huey,Lee Pui-Ching,Huo Teh-Ia,Lee Shou-Dong

Funder

National Yang-Ming University Hospital, Yilan, Taiwan

Taipei Veterans General Hospital

Publisher

Elsevier BV

Subject

Hepatology

Reference43 articles.

1. Rising incidence of hepatocellular carcinoma in the United States;El-Serag;N Engl J Med,1999

2. Hepatocellular carcinoma;Llovet;Lancet,2003

3. Prospective validation of the Barcelona Clinic Liver Cancer staging system;Cillo;J Hepatol,2006

4. Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004;10 (2 Suppl. 1):S115–20.

5. Discrimination value of the new Western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients;Ueno;Hepatology,2001

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Resection Criteria for Patients with Hepatocellular Carcinoma and Multiple Tumors Based on Total Tumor Volume;Digestive Diseases and Sciences;2024-06-01

2. Alpha-fetoprotein: Past, present, and future;Hepatology Communications;2024-04-12

3. Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal;Journal of Hepatology;2024-04

4. Performance status as a prognostic surrogate in hepatocellular carcinoma: Role of albumin–bilirubin and easy-albumin–bilirubin grade;Journal of the Chinese Medical Association;2023-12-12

5. Survival Benefit of Sequential Curative Treatment for TACE Suitable BCLC Stage B HCC Patients;2023-10-27